Institute of Biomedical Sciences, Academia Sinica Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2009
NCT02065388
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Institute of Biomedical Sciences, Academia Sinica

Active Ingredients

Drugs in Phase 3 Trials (1)

warfarin (coumadin) (1 trial)

Drugs in Other Trials (6)

citric acid (1 trial)

fish oil (Omegavan) (1 trial)

magnesium citrate (1 trial)

sucralose (1 trial)

vegetable protein (1 trial)

wheat (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Atrial Flutter (Phase 3)

Thrombosis (Phase 3)

Venous Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 7